176 related articles for article (PubMed ID: 9489976)
21. Mibefradil: a new class of calcium-channel antagonists.
Billups SJ; Carter BL
Ann Pharmacother; 1998 Jun; 32(6):659-71. PubMed ID: 9640486
[TBL] [Abstract][Full Text] [Related]
22. Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris.
Portegies MC; Schmitt R; Kraaij CJ; Braat SH; Gassner A; Hagemeijer F; Pozenel H; Prager G; Viersma JW; van der Wall EE
J Cardiovasc Pharmacol; 1991 Nov; 18(5):746-51. PubMed ID: 1723772
[TBL] [Abstract][Full Text] [Related]
23. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
Brogden RN; Markham A
Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
[TBL] [Abstract][Full Text] [Related]
24. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
25. Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension.
Oparil S; Kobrin I; Abernethy DR; Levine BS; Reif MC; Shepherd AM
Am J Hypertens; 1997 Jul; 10(7 Pt 1):735-42. PubMed ID: 9234827
[TBL] [Abstract][Full Text] [Related]
26. Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the Posicor Reduction of Ischemia During Exercise (PRIDE) trial.
Lee DS; Goodman S; Dean DM; Lenis J; Ma P; Gervais PB; Langer A;
Am Heart J; 2002 Jul; 144(1):60-7. PubMed ID: 12094189
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the effects of mibefradil and atenolol on regression of left ventricular hypertrophy in hypertensive patients.
Höglund C; Cifkova R; Mimran A; Tenczer J; Watt A; Wilkins MR; Lindberg E
Cardiology; 1998 May; 89(4):263-70. PubMed ID: 9643273
[TBL] [Abstract][Full Text] [Related]
28. The addition of mibefradil to chronic hydrochlorothiazide therapy in hypertensive patients is associated with a significant antihypertensive effect.
Carney S; Wing L; Ribeiro A; Kallwellis R; Zimlichman R; Viskoper RJ; Mion D; Kobrin I
J Hum Hypertens; 1997 Jul; 11(7):459-66. PubMed ID: 9283064
[TBL] [Abstract][Full Text] [Related]
29. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
30. Felodipine in addition to beta-adrenergic blockade for angina pectoris. a multicentre, randomized, placebo-controlled trial.
Rønnevik PK; Silke B; Ostergaard O
Eur Heart J; 1995 Nov; 16(11):1535-41. PubMed ID: 8881845
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the safety of mibefradil, a selective T-type calcium antagonist, in patients with chronic congestive heart failure.
van der Vring JA; Bernink PJ; van der Wall EE; van Velhuisen DJ; Braun S; Kobrin I
Clin Ther; 1996; 18(6):1191-206. PubMed ID: 9001836
[TBL] [Abstract][Full Text] [Related]
32. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
33. Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris: a multicenter parallel group study. The TRAFFIC Study Group.
Emanuelsson H; Egstrup K; Nikus K; Ellström J; Glud T; Pater C; Scheibel M; Tisell A; Tötterman KJ; Forsby M
Am Heart J; 1999 May; 137(5):854-62. PubMed ID: 10220634
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy and tolerability of two long-acting calcium antagonists, mibefradil and amlodipine, in essential hypertension. Mibefradil Hypertension Study Group.
Karch FE; Pordy R; Benz JR; Carr A; Lunde NM; Marbury T; Tarro JN
Clin Ther; 1997; 19(6):1368-78. PubMed ID: 9444446
[TBL] [Abstract][Full Text] [Related]
35. Mibefradil (posicor).
Giles TD
Compr Ther; 1997 Nov; 23(11):761-3. PubMed ID: 9360806
[No Abstract] [Full Text] [Related]
36. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
[TBL] [Abstract][Full Text] [Related]
37. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
38. Antihypertensive effects of mibefradil in the treatment of mild-to-moderate systemic hypertension.
Oparil S; Bernink P; Bursztyn M; Carney S; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):12C-19C. PubMed ID: 9286849
[TBL] [Abstract][Full Text] [Related]
39. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
[TBL] [Abstract][Full Text] [Related]
40. Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.
DiBianco R; Schoomaker FW; Singh JB; Awan NA; Bennett T; Canosa FL; Kawanishi DT; Bamrah VS; Glasser SP; Barry W
Clin Cardiol; 1992 Jul; 15(7):519-24. PubMed ID: 1354085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
